首页> 外文期刊>Antiviral Research >Progress on the development of therapeutics against West Nile virus.
【24h】

Progress on the development of therapeutics against West Nile virus.

机译:西尼罗河病毒治疗剂的开发进展。

获取原文
获取原文并翻译 | 示例
       

摘要

A decade has passed since the appearance of West Nile virus (WNV) in humans in the Western Hemisphere in New York City. During this interval, WNV spread inexorably throughout North and South America and caused millions of infections ranging from a sub-clinical illness, to a self-limiting febrile syndrome or lethal neuroinvasive disease. Its entry into the United States triggered intensive research into the basic biology of WNV and the elements that comprise a protective host immune response. Although no therapy is currently approved for use in humans, several strategies are being pursued to develop effective prophylaxis and treatments. This review describes the current state of knowledge on epidemiology, clinical presentation, pathogenesis, and immunobiology of WNV infection, and highlights progress toward an effective therapy.
机译:自从在纽约市的西半球人类中出现西尼罗河病毒(WNV)以来,已经过去了十年。在此间隔期间,WNV在北美和南美无情地传播,并导致数百万种感染,从亚临床疾病到自限性发热综合征或致死性神经侵袭性疾病。它的进入美国引发了对WNV基本生物学和构成保护性宿主免疫反应的元素的深入研究。尽管目前尚未批准任何疗法可用于人类,但仍在寻求几种策略来开发有效的预防和治疗方法。这篇综述描述了有关WNV感染的流行病学,临床表现,发病机理和免疫生物学的知识的现状,并着重介绍了有效治疗的进展。

著录项

  • 来源
    《Antiviral Research》 |2009年第3期|共14页
  • 作者

    Diamond MS;

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

  • 入库时间 2022-08-18 10:09:43

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号